about
Haplotype-based study of the association of alcohol and acetaldehyde-metabolising genes with alcohol dependence (with or without comorbid anxiety symptoms) in a Cape Mixed Ancestry population.Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individualsAre multiple physical symptoms a poor prognostic factor or just a marker of depression severity? Secondary analysis of the GenPod trial.Risk of suicide for individuals reporting asthma and atopy in young adulthood: findings from the Glasgow Alumni study.Systematic review and meta-analysis of serotonin transporter genotype and discontinuation from antidepressant treatmentThe low single nucleotide polymorphism heritability of plasma and saliva cortisol levels.Whole-Genome Sequencing Coupled to Imputation Discovers Genetic Signals for Anthropometric Traits.Carbonyl reductase 1 catalyzes 20β-reduction of glucocorticoids, modulating receptor activation and metabolic complications of obesity.Hair Cortisol in Twins: Heritability and Genetic Overlap with Psychological Variables and Stress-System Genes.Maternal and fetal genetic contribution to gestational weight gain.Genetic predictors of antidepressant side effects: a grouped candidate gene approach in the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association study.Genetic correlations among psychiatric and immune-related phenotypes based on genome-wide association dataOutcomes of non-infectious Paediatric uveitis in the era of biologic therapyIs population structure in the genetic biobank era irrelevant, a challenge, or an opportunity?Morning plasma cortisol as a cardiovascular risk factor: findings from prospective cohort and Mendelian randomization studiesCorrection to: Is population structure in the genetic biobank era irrelevant, a challenge, or an opportunity?
P50
Q33620292-50A417D6-6131-4D84-90B4-098AD4F0A2C7Q33906501-EEFEFAE9-1117-4F59-9116-3672B6240CCDQ35044690-BF4C1FD4-38FC-46DB-8784-A94AF029840EQ35078138-C626511C-D6A7-4377-A5F7-B568B5445077Q37217494-496C9300-4686-44BE-8852-FD10C819AC28Q38637063-CFC6D6E9-17AA-4A43-B04F-1921C8ECA3C4Q38759579-2E5F287A-867D-4FE4-832B-AFF434C0E6A8Q41637060-8367B81D-6A9F-4862-8F5E-4C9C0A9640CEQ45072666-B5F7FCD5-C3EB-4C88-B988-5E1B686CDBD0Q46271694-C15DF448-3889-4897-ABD9-2122038AD71DQ48372657-3266C489-C4B8-4E7A-A9C3-2D9F2111966CQ55374314-B7AACF2B-DCF1-49C5-B4BA-E46F67E4231EQ57455380-C509B3D4-0274-4279-8DE6-6A9F3513E5ADQ58799412-E68AECAE-4149-41FB-A2D6-5605ADFDCC51Q91571999-F4948DAD-6EA0-425C-BABB-94F24629A6C0Q92043414-E4A12B42-9710-4245-BFB0-8959DEC7681AQ92301289-BC46EE19-EAA8-4C61-917F-AD4F3986368F
P50
description
British geneticist
@en
British geneticist
@en-ca
British geneticist
@en-gb
geneticus
@nl
genetista británico
@es
عالم وراثة بريطاني
@ar
name
Andrew Crawford
@ast
Andrew Crawford
@en
Andrew Crawford
@es
Andrew Crawford
@nl
type
label
Andrew Crawford
@ast
Andrew Crawford
@en
Andrew Crawford
@es
Andrew Crawford
@nl
prefLabel
Andrew Crawford
@ast
Andrew Crawford
@en
Andrew Crawford
@es
Andrew Crawford
@nl
P108
P106
P1559
Andrew Crawford
@en
P21
P31
P496
0000-0002-9260-0315